Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NECITUMUMAB vs NELARABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NECITUMUMAB vs NELARABINE: Safety Overview

Metric NECITUMUMAB NELARABINE
Total FAERS Reports 367 735
Deaths Reported 69 156
Death Rate 18.8% 21.2%
Hospitalizations 131 265
Average Patient Age 65.4 yrs 29.3 yrs
% Female Patients 20.0% 30.1%
FDA Approval Date N/A Apr 4, 2023
Manufacturer Eli Lilly and Company Amneal Pharmaceuticals LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription